Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Proteome analysis of human neutrophil granulocytes from patients with monogenic disease using data-independent acquisition.

Grabowski P, Hesse S, Hollizeck S, Rohlfs M, Behrends U, Sherkat R, Tamary H, Ünal E, Somech R, Patıroğlu T, Canzar S, van der Werff Ten Bosch J, Klein C, Rappsilber J.

Mol Cell Proteomics. 2019 Jan 10. pii: mcp.RA118.001141. doi: 10.1074/mcp.RA118.001141. [Epub ahead of print]

2.

Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells In Vitro and In Vivo.

Delecluse S, Tsai MH, Shumilov A, Bencun M, Arrow S, Beshirova A, Cottignies-Calamarte A, Lasitschka F, Bulut OC, Münz C, Zeier M, Behrends U, Delecluse HJ.

J Virol. 2019 Feb 19;93(5). pii: e01618-18. doi: 10.1128/JVI.01618-18. Print 2019 Mar 1.

PMID:
30541846
3.

[Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines].

Lehrnbecher T, Groll A, Agyeman P, Ammann RA, Attarbaschi A, Behrends U, Berger C, Hamprecht A, Hufnagel M, Laws HJ, Scheler M, Temme C, Vieth S, Simon A.

Klin Padiatr. 2018 Apr;230(3):115-121. doi: 10.1055/s-0044-101953. Epub 2018 Mar 27. German.

PMID:
29589346
4.

Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.

Cirac A, Stützle S, Dieckmeyer M, Adhikary D, Moosmann A, Körber N, Bauer T, Witter K, Delecluse HJ, Behrends U, Mautner J.

Cancer Immunol Immunother. 2018 Apr;67(4):663-674. doi: 10.1007/s00262-018-2118-z. Epub 2018 Jan 27.

PMID:
29374782
5.

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, Zerweck J, Holenya P, Hanitsch LG, Wittke K, Borchmann P, Rüffer JU, Hiepe F, Ruprecht K, Behrends U, Meindl C, Volk HD, Reimer U, Scheibenbogen C.

PLoS One. 2017 Jun 12;12(6):e0179124. doi: 10.1371/journal.pone.0179124. eCollection 2017.

6.

A human immunodeficiency syndrome caused by mutations in CARMIL2.

Schober T, Magg T, Laschinger M, Rohlfs M, Linhares ND, Puchalka J, Weisser T, Fehlner K, Mautner J, Walz C, Hussein K, Jaeger G, Kammer B, Schmid I, Bahia M, Pena SD, Behrends U, Belohradsky BH, Klein C, Hauck F.

Nat Commun. 2017 Jan 23;8:14209. doi: 10.1038/ncomms14209.

7.

The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.

Fink S, Tsai MH, Schnitzler P, Zeier M, Dreger P, Wuchter P, Bulut OC, Behrends U, Delecluse HJ.

Transpl Int. 2017 Jan;30(1):57-67. doi: 10.1111/tri.12871. Epub 2016 Nov 5.

8.

Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring.

Körber N, Behrends U, Hapfelmeier A, Protzer U, Bauer T.

J Transl Med. 2016 Jun 14;14(1):175. doi: 10.1186/s12967-016-0932-7.

9.

Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group.

Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R.

Klin Padiatr. 2016 Apr;228(3):105-12. doi: 10.1055/s-0041-111180. Epub 2016 May 2. Review.

PMID:
27135270
10.

Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence?

Karastaneva A, Lanz S, Wawer A, Behrends U, Schindler D, Dietrich R, Burdach S, Urban C, Benesch M, Seidel MG.

Front Pediatr. 2015 Jun 8;3:50. doi: 10.3389/fped.2015.00050. eCollection 2015.

11.

Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing.

Fiebiger BM, Pfister H, Behrends U, Mautner J.

Eur J Immunol. 2015 Mar;45(3):716-27. doi: 10.1002/eji.201444830. Epub 2015 Jan 15.

12.

Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).

Bartelheim K, Sumerauer D, Behrends U, Kodetova D, Kucera F, Leuschner I, Neumayer P, Oyen F, Rübe C, Siebert R, Schneppenheim R, Seeringer A, Vasovcak P, Frühwald MC.

Cancer Genet. 2014 Sep;207(9):379-83. doi: 10.1016/j.cancergen.2014.04.005. Epub 2014 Apr 21.

PMID:
24972932
13.

Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders.

Linnerbauer S, Behrends U, Adhikary D, Witter K, Bornkamm GW, Mautner J.

PLoS Pathog. 2014 May 22;10(5):e1004068. doi: 10.1371/journal.ppat.1004068. eCollection 2014 May.

14.

Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.

Mynarek M, Schober T, Behrends U, Maecker-Kolhoff B.

Clin Dev Immunol. 2013;2013:814973. doi: 10.1155/2013/814973. Epub 2013 Sep 24. Review.

15.

Glucocorticoids augment survival and proliferation of tumor cells.

Gündisch S, Boeckeler E, Behrends U, Amtmann E, Ehrhardt H, Jeremias I.

Anticancer Res. 2012 Oct;32(10):4251-61.

PMID:
23060545
16.

Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.

Fiebiger BM, Moosmann A, Behrends U, Mautner J.

Eur J Immunol. 2012 Dec;42(12):3167-73. doi: 10.1002/eji.201242627. Epub 2012 Oct 16.

17.

Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation.

Milosevic S, Bachnick B, Karim K, Bornkamm GW, Witter K, Gerbitz A, Mautner J, Behrends U.

Transplantation. 2010 Nov 15;90(9):1030-5. doi: 10.1097/TP.0b013e3181f5470c.

PMID:
20802400
18.

First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child.

Grunewald TG, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, Konovalov D, Behrends U, Schiessl J, Wörtler K, Burdach S, von Luettichau I.

Ann Oncol. 2010 Aug;21(8):1733-4. doi: 10.1093/annonc/mdq331. Epub 2010 Jul 6. No abstract available.

PMID:
20605931
19.

Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature.

Grunewald TG, von Luettichau I, Weirich G, Wawer A, Behrends U, Prodinger PM, Jundt G, Bielack SS, Gradinger R, Burdach S.

Sarcoma. 2010;2010:431627. doi: 10.1155/2010/431627. Epub 2010 Apr 12.

20.

Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.

Busse C, Feederle R, Schnölzer M, Behrends U, Mautner J, Delecluse HJ.

J Virol. 2010 Jan;84(2):1139-47. doi: 10.1128/JVI.01953-09. Epub 2009 Nov 4.

21.

Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.

Delecluse HJ, Feederle R, Behrends U, Mautner J.

Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Review.

PMID:
18938248
22.

Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export.

Riedel A, Nimmerjahn F, Burdach S, Behrends U, Bornkamm GW, Mautner J.

Eur J Immunol. 2008 Aug;38(8):2090-5. doi: 10.1002/eji.200737900.

23.

Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.

Adhikary D, Behrends U, Feederle R, Delecluse HJ, Mautner J.

J Virol. 2008 Apr;82(8):3903-11. doi: 10.1128/JVI.02227-07. Epub 2008 Feb 13.

24.

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.

Adhikary D, Behrends U, Boerschmann H, Pfünder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J.

PLoS One. 2007 Jul 4;2(7):e583. Review.

26.

Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.

Feederle R, Neuhierl B, Baldwin G, Bannert H, Hub B, Mautner J, Behrends U, Delecluse HJ.

J Virol. 2006 Oct;80(19):9435-43.

27.

The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells.

Bornkamm GW, Behrends U, Mautner J.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7201-2. Epub 2006 May 1. No abstract available.

28.

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

Adhikary D, Behrends U, Moosmann A, Witter K, Bornkamm GW, Mautner J.

J Exp Med. 2006 Apr 17;203(4):995-1006. Epub 2006 Mar 20.

29.

Direct mapping of MHC class II epitopes.

Milosevic S, Behrends U, Christoph H, Mautner J.

J Immunol Methods. 2005 Nov 30;306(1-2):28-39. Epub 2005 Aug 31.

PMID:
16168435
30.

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.

Mautner J, Pich D, Nimmerjahn F, Milosevic S, Adhikary D, Christoph H, Witter K, Bornkamm GW, Hammerschmidt W, Behrends U.

Eur J Immunol. 2004 Sep;34(9):2500-9.

31.

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, Staudt LM, Rosenwald A, Behrends U, Bornkamm GW, Mautner J.

J Gen Virol. 2004 Aug;85(Pt 8):2347-56.

PMID:
15269376
32.

Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses.

Nimmerjahn F, Kobelt D, Steinkasserer A, Menke A, Hobom G, Behrends U, Bornkamm GW, Mautner J.

Eur J Immunol. 2003 Dec;33(12):3331-41.

33.

Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.

Behrends U, Schneider I, Rössler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Müller-Weihrich S, Graubner U, Schmid I, Sackerer D, Späth M, Goetz C, Prantl F, Asmuss HP, Bise K, Mautner J.

Int J Cancer. 2003 Aug 20;106(2):244-51.

34.

Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.

Nimmerjahn F, Milosevic S, Behrends U, Jaffee EM, Pardoll DM, Bornkamm GW, Mautner J.

Eur J Immunol. 2003 May;33(5):1250-9.

35.

Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.

Behrends U, Jandl T, Golbeck A, Lechner B, Müller-Weihrich S, Schmid I, Till H, Berthold F, Voltz R, Mautner JM.

Int J Cancer. 2002 Aug 20;100(6):669-77.

36.

Loss of myocardial capillary endothelial-cell alkaline phosphatase (ALP) activity in primary endothelial cell culture.

Lindner H, Behrends U, Misumi Y, Kremmer E, Eissner G, Schultz-Hector S.

Cell Tissue Res. 1998 Mar;291(3):497-505.

PMID:
9477306
38.

Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?

Holler E, Ertl B, Hintermeier-Knabe R, Roncarolo MG, Eissner G, Mayer F, Fraunberger P, Behrends U, Pfannes W, Kolb HJ, Wilmanns W.

Leuk Lymphoma. 1997 Apr;25(3-4):217-24. Review.

PMID:
9168432
39.

Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10.

Eissner G, Lindner H, Behrends U, Kölch W, Hieke A, Klauke I, Bornkamm GW, Holler E.

Transplantation. 1996 Sep 27;62(6):819-27.

PMID:
8824483
40.

c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.

Mautner J, Behrends U, Hörtnagel K, Brielmeier M, Hammerschmidt W, Strobl L, Bornkamm GW, Polack A.

Oncogene. 1996 Mar 21;12(6):1299-307.

PMID:
8649832
41.

Expression of ICAM-1 on intact cartilage and isolated chondrocytes.

Bujia J, Behrends U, Rotter N, Pitzke P, Wilmes E, Hammer C.

In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):116-22.

PMID:
8907125
42.

Ionizing radiation induces human intercellular adhesion molecule-1 in vitro.

Behrends U, Peter RU, Hintermeier-Knabe R, Eissner G, Holler E, Bornkamm GW, Caughman SW, Degitz K.

J Invest Dermatol. 1994 Nov;103(5):726-30.

Supplemental Content

Loading ...
Support Center